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Abstract
The ratio of the length of the index finger to that of the ring finger (2D:4D) is sexually dimorphic and is commonly used as a
non-invasive biomarker of prenatal androgen exposure. Most association studies of 2D:4D ratio with a diverse range of sex-
specific traits have typically involved small sample sizes and have been difficult to replicate, raising questions around the
utility and precise meaning of the measure. In the largest genome-wide association meta-analysis of 2D:4D ratio to date
(N¼15 661, with replication N¼75 821), we identified 11 loci (9 novel) explaining 3.8% of the variance in mean 2D:4D ratio. We
also found weak evidence for association (b¼0.06; P¼0.02) between 2D:4D ratio and sensitivity to testosterone [length of the
CAG microsatellite repeat in the androgen receptor (AR) gene] in females only. Furthermore, genetic variants associated with
(adult) testosterone levels and/or sex hormone-binding globulin were not associated with 2D:4D ratio in our sample.
Although we were unable to find strong evidence from our genetic study to support the hypothesis that 2D:4D ratio is a direct
biomarker of prenatal exposure to androgens in healthy individuals, our findings do not explicitly exclude this possibility,
and pathways involving testosterone may become apparent as the size of the discovery sample increases further. Our find-
ings provide new insight into the underlying biology shaping 2D:4D variation in the general population.
Introduction
It has long been hypothesized that prenatal sex steroids, partic-
ularly testosterone, permanently modify the developing ner-
vous system during critical periods of development, which in
turn influences behavior in later life (1). Whilst animal models
have largely supported this “Organizational hypothesis” (2), evi-
dence from human studies has been much more limited, as ac-
curately measuring prenatal testosterone exposure is extremely
difficult. Based on several lines of indirect evidence, it has
widely been hypothesized that the ratio of the length of the in-
dex finger to the length of the ring finger (2D:4D) is a marker of
prenatal androgen exposure (3) and could therefore be used as a
retrospective non-invasive biomarker of prenatal testosterone
exposure. Males are believed to have greater prenatal testoster-
one exposure than females, and this is thought to determine
the consistently observed lower ratio of the first (index) finger to
the third (ring) finger in males (4,5). This sex difference is rela-
tively stable over time (3,6,7), and although there is variation in
2D:4D ratio across ethnic groups (8,9), sexual dimorphism in the
digit ratio is consistent across ethnicities (10). Based on the as-
sumption that the digit ratio is a marker of prenatal testoster-
one exposure, associations have been reported between 2D:4D
ratio and a broad range of sex-dependent behaviors and dis-
eases including academic (11) and sporting performance (12,13),
social behaviors (14–16), fertility (17,18), Alzheimer’s disease
(19), metabolic syndrome indices (20) and autism spectrum dis-
order (21). Despite the extensive literature regarding 2D:4D ratio
(22), most published studies have used small sample sizes (of-
ten fewer than 100 individuals) and have been difficult to repli-
cate, raising questions around the utility and precise meaning
of the measure (23).
Several twin studies have indicated that 2D:4D ratio is highly
heritable (h2: 50–80%) (24–28). Two relatively small genome-
wide association studies (GWAS) of 2D:4D ratio have reported
two loci influencing variation in the trait (29,30). The minor al-
lele (A) at rs314277 in LIN28B was associated with increased
2D:4D ratio, delayed menarche in females (31) and increased
height (32). The minor allele (T) at the second locus, rs4902759
in SMOC1, was associated with decreased 2D:4D ratio. Pedigree
studies have shown that mutations in SMOC1 are associated
with Waardenburg anophthalmia (OMIM 206920), a syndrome
that commonly includes abnormal digits (33–35). Additionally,
the protein encoded by SMOC1 has been shown to be up-
regulated by androgens (36,37) and down-regulated by estrogen
(38), suggesting that SMOC1 could be an intermediate between
prenatal sex hormones and digit ratio (29).
Individuals with Complete Androgen Insensitivity Syndrome
(CAIS) exhibit more feminine 2D:4D ratios, consistent with an
effect of reduced prenatal testosterone exposure on digit ratio
(39). These individuals have mutations in the androgen receptor
(AR) gene, located on the X chromosome, which codes for a re-
ceptor protein that facilitates physiological responses to andro-
gens such as testosterone and dihydrotestosterone (40). In vitro
studies suggest that the variable number of CAG repeats in exon
1 of AR is inversely related to the efficiency with which the re-
ceptor complex binds to DNA and influences transcription (41).
Therefore, an association between the number of CAG repeats
at the AR locus and 2D:4D ratio may indicate that sensitivity to
androgens is a major driver of the individual differences in
2D:4D ratio seen in the normal population (40).
The aim of this study was to investigate the genetic determi-
nants of 2D:4D ratio by performing the largest GWAS
meta-analysis (N¼ 15 661, with replication N¼ 75 821) to date.
In addition, we aim to leverage genetics to scrutinize the evi-
dence surrounding the hypothesis that 2D:4D ratio reflects pre-
natal androgen exposure. Specifically, we investigated whether
there was association between repeat number in the androgen
receptor (XAR) and 2D:4D ratio and we used our GWAS results
to examine: (1) whether there was any association between
2D:4D ratio and genetic variants in pathways known to be
linked with androgens; and (2) whether there was any relation-
ship between 2D:4D ratio and genetic markers known to be re-
lated to (adult) levels of testosterone and/or sex hormone
binding globulin (SHBG). We hypothesize that if 2D:4D ratio is
truly influenced by levels of prenatal testosterone in utero, then
it is reasonable to expect that genetic variants related to
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androgen sensitivity (XAR) and/or serum levels of testosterone/
SHBG might also show association with 2D:4D ratio.
Results
Study population
Table 1 provides a summary of the studies included in the
meta-analysis. Full details of the studies in the discovery meta-
analysis and replication, including how the 2D:4D ratio was
measured and the genotyping methods, are provided in the
Supplementary Material. As expected, females had greater
2D:4D ratios than males in all cohorts. The mean and standard
deviation of 2D:4D ratios measured on skeletal images (the
Generation R Study and the Rotterdam Study) were lower than
those of the other cohorts measured on photocopies of the
hand, consistent with previous reports using this measure (42).
Genome-wide complex trait analysis of 2D:4D ratio of
the left hand, right hand and mean of both hands
Univariate genetic restricted maximum likelihood (GREML) analy-
sis in ALSPAC revealed that common genome-wide variation
explained a substantial proportion of the variance in 2D:4D ratio
(left: h2SNP ¼ 0.299, SE¼ 0.071, P¼ 4.6  106; right: h2SNP¼0.360,
SE¼ 0.071, P¼ 6.2 x 108; mean: h2SNP ¼ 0.373, SE¼ 0.071, P¼ 1.4 
108). The genetic correlation between the left and right hand ra-
tios was not different from 1 (rg ¼ 0.918, SE¼ 0.074, P¼ 0.14), indi-
cating that the vast majority of SNPs contributing to variation in
the ratio influence both hands. Therefore, in the main text we
present the results from the left (typically non-dominant) hand
ratio, due to the larger sample size achieved by including the
Generation R Study, and include the right hand and mean ratio
results in the Supplementary Material.
New genetic loci associated with 2D:4D ratio
The meta-analysis of approximately 8.4 million 1000 genomes-
imputed SNPs, including SNPs on the X chromosome, indicated
that the lowest observed P-values for each of the three ratios de-
viated from the expected null distribution (Supplementary
Material, Fig. S1), whereas systematic inflation of the test statis-
tics due to bias was negligible (kleft ¼ 1.020, kright ¼ 1.012, kmean ¼
1.014). Further, no evidence of heterogeneity was detected be-
tween the discovery cohorts (Supplementary Material, Fig. S2).
Eleven genomic loci reached genome-wide significance (P< 5 
108) in the discovery meta-analysis of 15 661 individuals for
2D:4D ratio [Fig. 1 for Manhattan plots from the GWAS of the left
hand (European only), Supplementary Material, Fig. S3 for the left
hand (multiethnic), right hand and average of both hands].
Conditional and joint analysis in the genome-wide complex trait
analysis (GCTA) software (43) identified two independent signals
in the 16q12.1 locus, totaling 12 independent signals across the
three 2D:4D ratio measurements. All 12 signals were replicated in
75 821 (52.8% male) research participants from 23andMe, Inc. (all
P< 0.004; Table 2). Of the nine loci reaching genome-wide signifi-
cance for the first time, six have not previously been described in
the context of 2D:4D ratio, including: rs11581730 on chromosome
1q22; rs12474669 on chromosome 2q31.1; rs77640775 on chromo-
some 7p14.1; rs10790969 on chromosome 11q24.3; rs6499762 and
rs1080014 on chromosome 16q12.1; and rs4799176 on chromo-
some 18q23. Two of the nine novel loci were reported at a sugges-
tive significance level (but not genome-wide) in Medland et al.
(30): SNPs in LDAH (previously known as C2orf43) on chromosome
2p24.1 and in GLIS1 on chromosome 1p32.3. The locus on chro-
mosome 2q31.1 is near the HOXD cluster of genes that are hy-
pothesized to be required for growth and patterning of the digits,
but this is the first time that convincing evidence for genetic as-
sociation with 2D:4D ratio has been obtained. The remaining two
loci included SNPs in LIN28B, identified previously by Medland
et al. (30) and SMOC1, reported by Lawrance-Owen et al. (29). A
summary of the meta-analysis results for the lead SNPs at each
locus that reached genome-wide significance in the discovery
sample are provided in Table 2, with the results from each study
presented in Supplementary Material, Table S3 and regional plots
in Supplementary Material, Figure S4. The lead SNPs at the 12
replicated signals together explain 3.8% of the variance in 2D:4D
ratio; this is equivalent to over half of the variance explained by
sex in the Raine Study (5.1%).
We conducted analysis of the X chromosome to investigate
whether there was evidence for 2D:4D ratio being partly an X-
linked trait. No SNPs on the X chromosome reached genome-
wide or suggestive significance (Fig. 1). The HOXA gene cluster,
along with the HOXD gene cluster, plays an important role in
limb development, and were initially thought to be essential for
the development of the 2D:4D ratio. Although the HOXD region
was associated with 2D:4D ratio in our meta-analysis, there was
no strong evidence for association between variants in the
HOXA cluster and 2D:4D ratio (439 SNPs with all P> 0.001,
Supplementary Material, Fig. S5).
Table 1. Descriptive statistics of the discovery and replication cohorts
Variable Subset ALSPAC Generation R QIMR Raine Rotterdam Study Twins UK
N All 5337 3059 2775 1003 2091 1396
Age (years)a All 11.74 (0.23) 9.80 (0.33) 15.47 (2.93) 20.05 (0.43) 67.84 (7.91) 54.84 (12.21)
Sex (male)b All 49% (2615) 47.9% (1465) 46.4% (1287) 50.85% (510) 42.9% (897) 9.10% (127)
Left 2D:4Da All 96.53 (3.25) 91.15 (2.72) 97.66 (3.41) 96.52 (3.45) 92.40 (2.24) 96.70 (3.40)
Male 96.05 (3.17) 90.74 (2.77) 96.87 (3.38) 96.16 (3.33) 91.96 (2.25) 95.25 (3.24)
Female 97.00 (3.26) 91.52 (2.62) 98.33 (3.29) 96.93 (3.53) 92.73 (2.17) 96.80 (3.42)
Right 2D:4Da All 96.37 (3.28) – 97.07 (3.43) 96.99 (3.28) 92.39 (2.42) 97.10 (3.50)
Male 95.87 (3.22) – 96.12 (3.29) 96.81 (3.28) 91.94 (2.39) 95.58 (3.38)
Female 96.87 (3.26) – 97.88 (3.33) 97.19 (3.28) 92.73 (2.39) 97.24 (3.48)
Mean 2D:4Da All 96.45 (2.99) – 97.39 (3.10) 96.76 (3.04) 92.40 (2.12) 96.90 (3.10)
Male 95.96 (2.90) – 96.51 (3.01) 96.48 (2.94) 91.95 (2.13) 95.42 (2.99)
Female 96.93 (3.00) – 98.14 (2.97) 97.06 (3.12) 92.71 (2.05) 97.02 (3.07)
aMean (SD).
bPercent (number).
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As a secondary analysis, we also conducted sex-stratified
analyses in each of the discovery cohorts and combined the
results using a fixed-effects meta-analysis. The majority of the
loci reaching genome-wide significance in the male or female
only analyses were identified in the combined analysis (Miami
plots in Supplementary Material, Fig. S6). One novel locus
reached genome-wide significance in the female only analysis
of the left hand 2D:4D ratio in the multi-ethnic meta-analysis.
The top SNP in this region, rs10105686 [C allele (allele
frequency¼ 0.79) females: b ¼ 0.334, P ¼ 2.42  109; males: b
¼ 0.024, P ¼ 0.71], is in FGFR1 on chromosome 8. However, this
locus only reached genome-wide significance for the left hand
2D:4D ratio in the multi-ethnic meta-analysis (P¼ 3.4  107 in
the female left hand European analysis), and would not be de-
clared significant after correction for multiple testing given the
large numbers of secondary analyses performed [i.e. secondary
analyses involved analysis of males, females, left hand (both
European and multi-ethnic analyses), right hand and average
2D:4D ratio, plus four sets of genome-wide sex heterogeneity
analysis].
Gene by sex interaction
GREML analysis in ALSPAC showed no significant indication of
gene by sex interaction (left: vgxe ¼ 0.000, SE¼ 0.138, P¼ 0.5; right:
vgxe ¼ 0.117, SE¼ 0.144, P¼ 0.21; mean: vgxe ¼ 0.000, SE¼ 0.140,
P¼ 0.5). Consistent with this, only one locus on chromosome 9
reached genome-wide significance for difference in the magni-
tude of the regression coefficients between males and females for
the average of both hands 2D:4D ratio (top SNP, rs16929125, A al-
lele frequency¼ 0.91, heterogeneity P¼ 1.17  108;
Supplementary Material, Fig. S7 for Manhattan plots and
Supplementary Material, Fig. S8 for QQ plots). However, this locus
only reached genome-wide significance for average 2D:4D ratio,
and would not be declared significant after correction for multiple
testing given the large number of secondary analyses performed.
Gene prioritization, pathway and tissue analysis
We used Data-driven Expression-Prioritized Integration for
Complex Traits (DEPICT) (44) to identify the most likely causal
gene at each locus and to investigate enriched pathways.
DEPICT identified the nearest gene to the top associated signal
to be the most likely causal gene in 10 of our 12 signals
(Supplementary Material, Table S4); GLIS1, LDAH (previously
known as C2orf43), OLA1, LIN28B, GLI3, FLI1, SMOC1, SALL1, TOX3
and SALL3. At the 2q31.1 locus, DEPICT prioritized two genes,
HODX11 and HOXD12, whilst at the 1q22 locus, five genes were
prioritized: EFNA1, DPM3, EFNA3, KRTCAP2 and SLC50A1. We
will subsequently refer to this locus as EFNA1, which is the
nearest gene to the top association signal.
When using the meta-analysis results from the average
2D:4D ratio of both hands, one gene set reached a false discov-
ery rate (FDR) P< 0.01, which mapped to the MSX1 PPI sub-
network (Supplementary Material, Table S5). The tissue enrich-
ment analysis did not identify any tissues with a FDR P< 0.01
(Supplementary Material, Table S6). Based on the expression
data of 53 tissue types from the Genotype-Tissue Expression
(GTEx) Consortium, four of the nearest genes to our lead SNPs
showed high tissue expression in the testis or adrenal gland
(LDAH, LIN28B, SMOC1 and C16orf97; Supplementary Material,
Fig. S9) relative to the other available tissues. Three of these
four also showed expression in the brain (LDAH, LIN28B and
SMOC1), in addition to two nearest genes, which showed high
expression in the brain (OLA1 and SALL3).
Association between 2D:4D ratio and testosterone
sensitivity
We examined the association of 2D:4D ratio variation with the
length of an established CAG repeat polymorphism in the AR
gene, a proxy of testosterone sensitivity, in a meta-analysis of
the ALSPAC and QIMR cohorts. We found nominal evidence for
a weak positive association between the number of CAG repeats
in the AR gene on the X chromosome and mean 2D:4D ratio in
females (mean of repeats: b¼ 0.056, P¼ 0.02; lower length re-
peat: b¼ 0.047, P¼ 0.03), but not in males (cf. Table 3, see
Supplementary Material, Table S7 for left and right 2D:4D ratio).
The 91 SNPs in AR in the GWAS showed little evidence for
association with 2D:4D ratio (minimum P¼ 0.03; Supplementary
Material, Fig. S10).
2D:4D associated variants and other traits
Given the putative relationship between prenatal testosterone
levels and 2D:4D ratio, we also examined the association
Figure 1. Manhattan plot from the discovery meta-analysis of left hand 2D:4D ratio. The horizontal black line indicates genome-wide significance (P<5  108). Black
dots indicate those loci that reach genome-wide significance.
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between five published SNPs (rs12150660, rs5934505, rs10822186,
rs10822184 and rs72829446) shown to influence testosterone
levels (45,46) using our 2D:4D ratio meta-analysis of the discov-
ery cohorts; one other reported SNP was not tested, rs6258, as it
was excluded from our meta-analysis as the minor allele
frequency was<1%. Due to the high correlation between testos-
terone and its principal binding protein, SHBG, we also tested
the association between the 13 published loci for SHBG (47, 48)
and 2D:4D ratio. We observed three associations with left hand
2D:4D ratio at P< 0.05: the C allele at rs1641537 (allele
frequency¼ 0.87) was associated with increased 2D:4D ratio
(b¼ 0.111, P¼ 0.05) and increased SHBG, the T allele at rs1573036
(allele frequency¼ 0.39) was associated with decreased 2D:4D
ratio (b ¼ 0.077, P¼ 0.02) and increased SHBG and the T allele
at rs72829446 (allele frequency¼ 0.11) was associated with
increased 2D:4D ratio (b¼ 0.123, P¼ 0.04) and increased testos-
terone (Fig. 2) (i.e. two out of the three associations were in the
opposite direction to expected). We also failed to detect enrich-
ment for association with 2D:4D ratio over all 18 testosterone
and SHBG SNPs (Fisher’s combined probability test P¼ 0.10).
Additionally, there was no difference in the male and female
effect sizes from the sex-stratified analyses across the 18 SNPs
(Fisher’s combined probability test for the heterogeneity
P¼ 0.23). Only one SNP, rs3779195, showed heterogeneity
between males and females with the SHGB increasing T allele
negatively associated with 2D:4D ratio in males and positively
associated with 2D:4D ratio in females (bmale ¼ 0.183, Pmale ¼
0.01; bfemale ¼ 0.053, Pfemale ¼ 0.39; Phet ¼ 0.01).
Given the previous observational epidemiological associa-
tions between 2D:4D ratio and sex-dependent behaviors, we
Table 2. Genome-wide-significant loci from the discovery meta-analysis in all individuals for left hand 2D:4D ratio; the most significant SNP
from each locus is presented
Chr Position [bp
(GRCh37/hg19)]
Nearest gene Effect allele/
other allele
EAFa Beta SE P-value
rs4927012
Discovery 1 54068016 GLIS1 T/C 0.875 0.358 0.058 5.08  1010
Replication 1 54068016 GLIS1 T/C 0.871 0.042 0.006 3.48  1012
rs11581730
Discovery 1 155082158 EFNA1 A/T 0.496 0.294 0.036 3.02  1016
Replication 1 155082158 EFNA1 A/T 0.503 0.026 0.004 4.99  1011
rs340600
Discovery 2 20892006 LDAHb T/G 0.199 0.379 0.046 1.38  1016
Replication 2 20892006 LDAHb T/G 0.199 0.043 0.005 1.81  1017
rs12474669
Discovery 2 175134232 OLA1 A/G 0.139 0.417 0.054 1.51  1014
Replication 2 175134232 OLA1 A/G 0.143 0.043 0.006 1.92  1013
rs847158
Discovery 2 176962102 HOXD12/HOXD11 A/G 0.602 0.199 0.037 1.03  107
Replication 2 176962102 HOXD12/HOXD11 A/G 0.609 0.039 0.004 3.04  1020
rs314277c
Discovery 6 105407662 LIN28B A/C 0.155 0.428 0.050 5.55  1018
Replication 6 105407662 LIN28B A/C 0.149 0.067 0.006 1.77  1032
rs77640775d
Discovery 7 42190714 GLI3 A/G 0.137 0.252 0.053 1.92  106
Replication 7 42190714 GLI3 A/G 0.146 0.033 0.006 6.64  109
rs10790969
Discovery 11 128529842 FLI1 T/C 0.276 0.284 0.040 1.33  1012
Replication 11 128529842 FLI1 T/C 0.272 0.027 0.005 1.26  109
rs2332175c
Discovery 14 70345411 SMOC1 A/G 0.529 0.360 0.037 3.00  1022
Replication 14 70345411 SMOC1 A/G 0.546 0.045 0.004 6.74  1029
rs6499762
Discovery 16 51697874 SALL1 A/C 0.125 0.441 0.056 5.33  1015
Replication 16 51697874 SALL1 A/C 0.129 0.083 0.006 2.83  1041
rs1080014
Discovery 16 51900171 TOX3 C/T 0.514 0.203 0.036 1.94  108
Replication 16 51900171 TOX3 C/T 0.501 0.012 0.004 3.35  103
rs4799176
Discovery 18 76378307 SALL3 C/T 0.256 0.305 0.044 4.09  1012
Replication 18 76378307 SALL3 C/T 0.244 0.057 0.005 1.89  1034
Replication results are presented from 23andMe where the 2D:4D ratio was reported as a relative measure [i.e. 0¼ index finger longer (17.1% of research participants),
1¼ index and ring finger the same length (14.0% of research participants), 2¼ ring finger longer (68.9% of research participants)].
aAverage effect allele frequency (EAF) across the cohorts in each of the meta-analyses.
bPreviously known as C2orf43.
cGenetic loci that had previously been associated with 2D:4D ratio in Medland et al. (30).
dSNP passed genome-wide significance in the average 2D:4D ratio meta-analysis (see Supplementary Material for results).
2029Human Molecular Genetics, 2018, Vol. 27, No. 11 |
Downloaded from https://academic.oup.com/hmg/article-abstract/27/11/2025/4969373
by University Library user
on 06 June 2018
used publicly available GWAS summary results for a variety
of traits to estimate genetic correlations with 2D:4D ratio us-
ing linkage-disequilibrium (LD) score regression (49). We pre-
sent the genetic correlation results in Supplementary
Material, Table S8, but advise caution in their interpretation,
considering the recommendation by Bulik-Sullivan et al. (49)
regarding conducting genetic correlation analysis for traits
with heritability z-scores below 4, as the estimates tend to be
noisy and less reliable (the z-scores for the left hand, right
hand and average of both hands were 2.9, 3.0 and 3.3,
respectively).
Discussion
The 2D:4D ratio, a sexually dimorphic trait, has been extensively
used in adults as a biomarker for prenatal androgen exposure.
In the largest genetic association study of 2D:4D ratio to date,
we identified nine novel loci for 2D:4D ratio, in addition to repli-
cating two previously identified loci, LIN28B and SMOC1. These
11 loci explained 3.8% of the variance in mean 2D:4D ratio. After
assessing association between 2D:4D ratio and a range of testos-
terone-related traits, we found no conclusive evidence of the
2D:4D ratio constituting a marker of prenatal androgen expo-
sure, although it is possible that pathways involving testoster-
one may become apparent as the size of our GWAS increases in
the future. Yet, associations at distinct novel loci provide addi-
tional insight into the underlying biology shaping 2D:4D ratio
variation.
The association signal on 1p32.3 spans GLIS1, which is
expressed across several organs in the reproductive system, in-
cluding the prostate, vagina, testis and cervix. Glis1, the protein
encoded by GLIS1, is a Kruppel-like zinc finger protein that
appears to have a critical role in controlling gene expression
during specific stages of embryogenesis (50).
Table 3. Association between the number of CAG repeats in the AR gene and the mean of the left and right hand 2D:4D ratios
ALSPAC QIMR Meta-analysis
All individuals
N ¼ 5328 N ¼ 498 N ¼ 5826
Mean 0.014 (0.016), P ¼ 0.19 0.040 (0.052), P ¼ 0.22 0.016 (0.015), P ¼ 0.14
High 0.012 (0.015), P ¼ 0.21 0.014 (0.046), P ¼ 0.38 0.012 (0.014), P ¼ 0.20
Low 0.013 (0.016), P ¼ 0.21 0.041 (0.057), P ¼ 0.24 0.015 (0.015), P ¼ 0.16
Male
N ¼ 2615 N ¼ 231 N ¼ 2846
Mean 0.002 (0.020), P ¼ 0.54 0.099 (0.083), P ¼ 0.88 0.007 (0.019), P ¼ 0.65
Female
N ¼ 2713 N ¼ 287 N ¼ 3000
Mean 0.046 (0.028), P ¼ 0.05 0.125 (0.072), P ¼ 0.04 0.056 (0.026), P ¼ 0.02
High 0.030 (0.025), P ¼ 0.12 0.068 (0.058), P ¼ 0.12 0.036 (0.023), P ¼ 0.06
Low 0.040 (0.026), P ¼ 0.06 0.112 (0.082), P ¼ 0.09 0.047 (0.025), P ¼ 0.03
Displayed are beta (SE) and P-values in each of the cohorts and the combined estimates from the fixed effects, inverse-variance weighted meta-analysis. ‘Mean’ refers
to analyses involving the average CAG repeat length, ‘High’ refers to analyses involving the highest length repeat and ‘Low’ refers to analyses involving the lower
length repeat. One-tailed P-values testing for a positive association between CAG repeat length and 2D:4D ratio are presented.
Figure 2. Plots highlighting the relationship of 13 SHBG and five testosterone associated SNPs (45–48) with the left hand 2D:4D ratio discovery meta-analysis. (A) Q-Q
plot of the meta-analysis P-values for each of the SNPs. (B) Plot of the b coefficient for the left hand 2D:4D ratio meta-analysis against the b coefficient previously
reported for SHBG or testosterone (the 13 SHBG associated SNPs are aligned to the SHBG increasing allele and the five testosterone associated SNPs are aligned to the
testosterone increasing allele). Triangles indicate SNPs associated with testosterone, circles indicate SNPs associated with SHBG.
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At 1q21-q22, the closest gene to the associated variants is
EFNA1, which encodes a member of the ephrin family and has
been implicated in mediating developmental events, notably in
the nervous system. SNPs in the region of EFNA1, DPM3 and
KRTCAP3 have previously been associated with prostate cancer
risk (51) and c-glutamyl transferase (GGT), an indicator of liver
disease (52). Based on the results from GTEx, EFNA1 is also
mainly expressed in the liver, which is the most active site of
lipid metabolism. A proxy for our lead 2D:4D ratio associated
SNP at this locus, rs11264329, was associated with total and LDL
cholesterol levels (53). Additionally, the top SNP identified at
2p24.1 is in LDAH (previously known as C2orf43); SNPs in LDAH
have also been associated with prostate cancer risk (54,55). The
protein encoded by LDAH is involved in cholesterol mobilization
(56). Testosterone, which is linked to prostate cancer risk, is cre-
ated when luteinizing hormone (LH) triggers the testicular
Leydig cells to convert cholesterol to testosterone. Therefore,
these two loci could implicate cholesterol metabolism in ste-
roidogenesis as a link to testosterone exerting a role on 2D:4D
ratio variation, albeit requiring further investigation into the
functional implications.
OLA1, which maps to the 2q31.1 locus, plays multiple roles
in the regulation of cell proliferation and cell survival. Ding et al.
show that mouse embryos lacking OLA1 have delayed develop-
ment leading to immature organs and stunted growth, which
were frequently lethal prenatally (57). Their data suggests that
there is a defect in cell proliferation due to a delay in cell cycle
progression meaning that the mutant embryos appeared to un-
dergo fewer proliferation cycles resulting in growth restriction.
SNPs in the 7p14.1 region map within GLI3. The gene enco-
des a zinc finger transcription factor that functions in the
hedgehog signal transduction pathway. SNPs in this region
have also been associated with facial morphology, namely nose
wing breadth (58), and implicated in several Mendelian disor-
ders which are characterized by craniofacial and limb abnor-
malities. Specifically, there are several disorders and conditions
where polydactyly is a feature (59), including Greig cephalopoly-
syndactyly syndrome (GCPS), and Pallister-Hall syndrome (PHS).
There is some evidence for brachydactyly (shortened digits) in a
mouse null Gli3 mutant developed by Sheth et al. (60), and in
patients with PHS (59).
The association signal arising from the 11q24.1-q24.3 locus
is intergenic between FLI1 and ETS1. Through GWAS, SNPs in
the FLI1 gene have been shown to be associated with height,
with similar effects in both males and females (61). In addition,
SNPs in ETS1 have been shown to be associated with rheuma-
toid arthritis (62) and celiac disease (63) in European popula-
tions and with systemic lupus erythematosus (64–66) in
Chinese populations; all of these diseases have a higher preva-
lence in females. This gene encodes the protein Ets1, which is
expressed in a variety of tissues throughout the development of
an embryo and plays a role in pituitary hormone secretion (67).
In mice, the ETS factor family defines Shh spatial expression in
limb buds and alterations define pathogenetic mechanism lead-
ing to preaxial polydactyly (68).
The GWAS signal on chromosome 16q12.1 maps in the vicin-
ity of the SALL1, TOX3 and C16orf97 genes. Not much is known
about the function of C16orf97. However, SALL1 was identified
by DEPICT as being the most likely causal gene for the rs6499762
association; mutations in SALL1 cause Townes-Brocks syn-
drome (69), a condition characterized by hand malformations,
abnormally shaped ears and anal atresia, among other genital
malformations (70). Additionally, SALL3 on chromosome 18q23,
is also part of the human spalt-like gene family, which is associ-
ated with syndromic forms presenting with skeletal abnormali-
ties. Kohlhase et al. (71) characterized this gene and implicated
it in the 18q deletion syndrome, which results in mental and
growth retardation, developmental delay, hearing loss, and fa-
cial and limb abnormalities including tapered fingers (72).
Altogether, several links between 2D:4D ratio and testosterone
metabolism can be derived from these associations, involving
hormonal pathways and the process of sexual differentiation
during early development. Further, SNPs in the SALL3 region
have also been associated with prostate cancer (51), which may
suggest additional links between 2D:4D ratio and testosterone.
One gene set was identified as being associated with 2D:4D
ratio, the MSX1 PPI subnetwork. An Msx1-interacting network of
transcription factors has been shown to operate during early
tooth development (73). Therefore, the identification of this
gene set may be highlighting a network that is involved in sev-
eral areas of development.
Interestingly, we didn’t find strong evidence of association
between variants within the HOXA gene cluster and 2D:4D ratio.
This lack of association does not preclude variation in distal
enhancers acting through effects on the expression of HOXA
cluster genes nor that variants of smaller effect act from within
the cluster itself [with an alpha of 5  108 we had 80% power to
detect a genetic variant that explained approximately 0.28% of
the variance in the left hand 2D:4D ratio in Europeans only
(N¼ 14 382)]. We did, however, find an association involving a
variant in HOXD12 (the most strongly associated SNP was
rs847158, P¼ 9.58  1011, which replicated in the 23andMe
dataset). The exact role of HOXD12 has not yet been determined;
however, the homeobox family of genes plays an important role
in morphogenesis and is particularly relevant in the develop-
ment of the limbs and genitals (74).
2D:4D ratio as a marker of testosterone exposure
2D:4D ratio has been used extensively in adults as a biomarker
for prenatal androgen exposure. However, whether the digit ra-
tio reliably reflects prenatal androgen exposure has not been
convincingly demonstrated. Most of the data linking 2D:4D ratio
with prenatal androgen exposure is based on preclinical or indi-
rect evidence, including studies that indicate that 2D:4D ratio is
fixed early in gestation and is associated with adult levels of cir-
culating testosterone (3,75). The most direct test of this hypothe-
sis to date was performed by Lutchmaya et al. who showed that
testosterone levels in amniotic fluid from the second trimester
of pregnancy were not associated with 2D:4D ratio at 2 years of
age (76). However, the authors did find that an increased ratio of
testosterone to estradiol was associated with a lower (or more
male like) 2D:4D ratio, suggesting that the relationship between
digit ratio and prenatal hormones may be more complicated and
not only reflect testosterone levels (76,77).
In the present study we attempted to use genetic evidence to
find support for the testosterone biomarker hypothesis. Our ratio-
nale was that if prenatal testosterone affects 2D:4D ratio, then it
is logical that polymorphisms in genes related to androgen sensi-
tivity (e.g. in XAR) and/or SNPs robustly associated with androgen
levels/levels of SHBG, should also be related to 2D:4D ratio. Whilst
we did detect some evidence of a positive association between
the number of CAG repeats in AR and 2D:4D ratio in females, we
note that the small effect size would not be significant after
adjusting for the multiple statistical tests we performed. Power
calculations suggest that our combined sample of N¼ 5826
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individuals in the XAR meta-analysis was well powered (78%) to
detect a locus responsible for 0.001% of the phenotypic variance
in 2D:4D ratio (one-tailed a¼ 0.05). In comparison, all of our
genome-wide significant SNPs explained>0.001% of the variance
in 2D:4D ratio (most explained much more variance than this).
This suggests that if genetic variation in XAR does contribute to
variation in 2D:4D ratio through, for example, sensitivity to tes-
tosterone, its effect is likely to be small relative to other sources
of genetic variation. Two recent smaller meta-analyses also failed
to find an association between length of the repeat in XAR and
2D:4D ratio (78,79).
Likewise, using SNPs that are associated with testosterone
and SHBG, we were unable to detect any enrichment for associ-
ation with 2D:4D ratio. We were also unable to identify any ge-
netic correlation between 2D:4D ratio and a range of traits and
diseases previously implicated with 2D:4D ratio variation. This
indicates that the previously identified observational associa-
tions may not be driven by known genetic loci that are shared
between the traits, although we acknowledge the power of
analysis was low and confidence intervals around our estimates
were large.
Whilst we were unable to find any convincing evidence that
sensitivity to/levels of androgens is a major driver of the individual
differences in 2D:4D ratio seen in the normal population, there are
several key assumptions underlying the use of genetic variation to
investigate the link between prenatal androgen exposure and
2D:4D ratio. First, investigating the association between the num-
ber of CAG repeats in AR and 2D:4D ratio relies on the assumption
that CAG length reflects androgen sensitivity. There is fairly good
evidence for this, at least in vitro as derived from the Chamberlain
et al. functional study showing a linear relationship between in-
creased CAG length and decreased transactivation function (41).
Second, we assume that the genotyping of the CAG repeat is accu-
rate. Although there was some discordance in the replicate geno-
typing in ALSPAC, the majority of discrepancies were only one
CAG repeat different between the replicates. Our simulations pre-
sented in the Supplementary Material indicate that this degree of
measurement error had little influence on the power of our associ-
ation analysis. Third, we assume that the SNPs associated with
adult levels of testosterone/SHBG also reflect testosterone/SHBG
levels prenatally and that the effect of these SNPs are similar in
males and females. The testosterone-associated SNPs were identi-
fied in GWAS of adult men only and one of the two GWAS for
SHBG, identifying only one novel locus, was in post-menopausal
women only. However, Coviello et al. conducted sex-stratified
analyses and identified only one locus with significant heteroge-
neity on SHBG between males and females (48). They also showed
that the SHBG SNPs identified explained 15.6% of the variation in
SHBG in men and 8.4% of the variation in women. This indicates
that although the SNPs have a greater overall effect in males, they
are still likely to be associated with androgens in females. It is too
difficult to measure androgen levels in the fetus so we are unable
to confirm that these SNPs are also associated with androgen lev-
els prenatally. Finally, although none of our novel loci showed di-
rect evidence of being related to pathways involving testosterone,
it does not preclude the very real possibility that testosterone
influences 2D:4D ratio by down-regulating or up-regulating the ex-
pression of genes involved in its determination. Indeed, in GWAS
of height (80) and BMI (81), the role of expected hormone pathways
only appeared when the studies were sufficiently powered to find
far greater number of genome-wide significant hits than in the
present study.
In conclusion, we have conducted the largest GWAS of 2D:4D
ratio to date and identified nine novel loci robustly associated
with 2D:4D ratio in Europeans, bringing the total number of ro-
bustly associated loci to 11. We were unable to find strong evi-
dence from our genetic study to support the hypothesis that
2D:4D ratio is a direct biomarker of prenatal exposure to andro-
gens in healthy individuals, although our findings do not explic-
itly exclude this possibility, and pathways involving testosterone
may become apparent as the size of the discovery sample
increases further. Our findings provide new insight into the un-
derlying biology shaping 2D:4D variation in the general
population.
Materials and Methods
Participants
We drew on data from six cohorts for the discovery genome-
wide meta-analysis and association with the CAG repeat in AR
including the Avon Longitudinal Study of Parents and Children
(ALSPAC), the Generation R Study, the Rotterdam Study, the
Western Australian Pregnancy Cohort (Raine) Study, TwinsUK
and the Queensland Institute of Medical Research (QIMR) sam-
ple, which was drawn from the Brisbane Adolescent Twin Study
[BATS; also known as the Brisbane Longitudinal Twin Study
(BLTS)]. The 23andMe cohort was used for replication of the
genome-wide significant findings. Details of each of these stud-
ies, including how the 2D:4D ratio was measured and the geno-
typing methods, are provided in the Supplementary Material.
Ethics statement
All cohorts in the discovery meta-analysis or replication
obtained ethical approval from their local ethics review boards;
ALSAPC from the ALSPAC Law and Ethics Committee and the
Local Research Ethics Committees, The Generation R Study
from the Medical Ethics Committee of the Erasmus Medical
Center in Rotterdam, QIMR from the QIMR Human Research
Ethics Committee, the Raine study from the King Edward
Memorial Hospital and Princess Margaret Hospital for Children
Human Research Ethics Committees, the Rotterdam Study from
the Medical Ethics Committee of the Erasmus Medical Center in
Rotterdam, TwinsUK from the Guy’s and St Thomas’ (GSTT)
Ethics Committee and research participants from 23andMe pro-
vided informed consent and participated in the research online,
under a protocol approved by the external AAHRPP-accredited
IRB, Ethical & Independent Review Services (E&I Review).
Statistical analysis
The 2D:4D ratio was calculated as the length of the second digit
divided by the length of the fourth digit, multiplied by 100 so as
to avoid computational difficulties due to the low variance of
the trait. In all studies, the measure was normally distributed,
so no further transformation was applied.
Genome-wide complex trait analysis of 2D:4D ratio
To estimate the proportion of additive genetic variance in 2D:4D
ratio explained by directly genotyped SNPs, we conducted a uni-
variate GREML analysis using the GCTA software (82) in>4900
individuals from ALSPAC. Sex was included as a fixed effect in
the model. Bivariate GREML analysis (83) was used to estimate
the genetic correlation between the left and right hand 2D:4D
ratio, which will indicate whether the same genetic variants
contribute to variation in the ratio of each hand. Additionally, a
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gene by sex analysis was conducted using the gene by environ-
ment test, to indicate whether the SNPs associated with 2D:4D
ratio differed between males and females.
Genome-wide association analysis: discovery
Genome-wide association analysis using imputed dosages to
account for uncertainty in the imputation was performed using
linear regression in each cohort, adjusting for sex. In addition,
the QIMR and TwinsUK cohorts accounted for zygosity and re-
latedness. The Generation R Study (European subset), the
Rotterdam Study and Raine adjusted for four principal compo-
nents for population stratification. A sensitivity analysis to
maximize power was conducted by including all individuals of
the Generation R Study with adjustment for 20 principal compo-
nents to account for the multi-ethnic sample as performed ear-
lier (84–88). Results presented in the main text are derived from
the meta-analysis including the European subset only, with the
multi-ethnic analysis presented in the Supplementary Material.
SNPs were tested for association with left 2D:4D ratio, right
2D:4D ratio (all cohorts excluding the Generation R Study) and
the mean of the left and right hand 2D:4D ratios (all cohorts ex-
cluding the Generation R Study). Results were combined using
fixed-effects inverse-variance weighted meta-analysis in
METAL (89), adjusting for genomic control. Within each study,
SNPs with a MAF< 1%, an INFO score< 0.4 or R2 for imputation
quality< 0.3 were excluded from the meta-analysis and SNPs
that were reported in less than 50% of the total sample size
were excluded from further follow-up.
We also tested whether the regression coefficients differed
between males and females. We carried out genome-wide asso-
ciation analysis in males and females separately in each of the
discovery cohorts and, as with the main analysis, we excluded
variants with a MAF<1% and poor imputation quality (INFO
score<0.4 or R2 for imputation quality< 0.3). We performed a
fixed-effects inverse-variance weighted meta-analysis of each
sex in METAL (89), adjusting for genomic control. Finally, we ex-
cluded variants that were reported less than 50% of the male
and female sample sizes, and performed a chi-square test of
heterogeneity between the meta-analysed male and female
effects in METAL (89) to test for the difference between the ef-
fect sizes in males and females and produce an overall level of
significance.
Conditional and joint association analysis
We performed approximate conditional and joint SNP associa-
tion analysis using the GCTA software (43), which utilizes meta-
analysis summary statistics and LD structure from a reference
sample. We used this approach to identify additional signals in
regions of association, using a subset of 15 000 UK Biobank (90)
individuals as the reference sample to approximate LD patterns.
The selected subset of the UK Biobank individuals were of
European descent and unrelated to anyone else in the subset.
Genome-wide association analysis: replication
SNPs that reached genome-wide significance (P< 5  108 for
the left, right or average 2D:4D ratio) in the discovery meta-
analysis were replicated in the 23andMe dataset. If the imputed
SNP passed quality control or the genotyped SNP was unavail-
able, then the imputed SNP was used for analysis, otherwise the
genotyped SNP was used. Analysis of each SNP was performed
using linear regression, adjusting for sex, age, the first five prin-
cipal components for population stratification and genotyping
platform. Results were adjusted for a genomic control inflation
factor of k¼ 1.074.
Variance explained
The variance explained by each SNP was calculated using the
effect size from the discovery meta-analysis (beta, b), the minor
and major allele frequencies (p and q, respectively) and the vari-
ance of the 2D:4D ratio (Var(Y)) using the following formula:
VarExp ¼ 2pq b
2
VarðYÞ
We used the median standard deviation in 2D:4D ratio
across the cohorts, which was 3.40 for the left hand, 3.35 for the
right hand and 3.06 for the average of both hands to calculate
the phenotypic variance in this formula. Under the assumption
that all SNPs independently contribute to 2D:4D ratio, we com-
puted the total variance explained by the lead SNPs at the
genome-wide significant loci as the sum of the single-SNP
explained variances.
Gene prioritization, gene set and tissue/cell type enrichment analysis
We conducted three analyses implemented in DEPICT (44) to es-
tablish the functional connections with our lead signals. First,
we prioritized genes which are most likely to be causal for
2D:4D ratio by correlating the reconstituted gene set member-
ship of each gene nearby the associated signal to genes from
other associated loci and adjusting for potential sources of bias
such as gene size. Second, we performed a gene set enrichment
analysis, which tests if the genes in the associated loci are
enriched in the reconstituted gene sets. Third, we analysed ex-
pression enrichment across particular tissues or cell types, by
testing whether genes associated with 2D:4D ratio loci were
seen highly expressed in any of the 209 Medical Subject
Heading (MeSH) annotations using data from 37 427 expression
arrays. In all three analyses, we used FDR to adjust for multiple
testing, with an FDR P< 0.01 defined as significant.
The DEPICT analyses were based on independent lead SNPs
(r2< 0.1, European populations 1000 genomes reference panel)
with P-values below the genome-wide significant threshold
(P< 5  108). Gene-set enrichment was further grouped into
‘meta gene sets’ by similarity clustering, as described previously
(44).
Additionally, we investigated the functionality of the genes
closest to the lead SNPs identified in these analyses using ex-
pression data on 53 tissue types from the GTEx Consortium (91).
Analysis of the CAG repeat polymorphism in AR
Information on the CAG repeat polymorphism in AR was avail-
able in the ALSPAC and QIMR cohorts (see Supplementary
Material for genotyping information). In ALSPAC, we performed
linear regression of 2D:4D ratio (left, right and mean of the left
and right) on length of CAG repeat (in females either average re-
peat length, the highest length repeat or the lower length re-
peat). The QIMR analyses were conducted using full
information maximum likelihood structural equation models in
openMx (92) which explicitly accounted for relatedness and zy-
gosity while estimating the linear effect of the CAG repeat on
2D:4D ratio. We performed analyses including all participants
(with sex as a covariate), females separately and males sepa-
rately. A fixed-effects inverse-variance weighted meta-analysis
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was used to combine the results from the two cohorts using the
rmeta package in R (version 3.0.0) (93). A one-tailed hypothesis
was used to test whether there was a positive association be-
tween the number of CAG repeats and 2D:4D ratio.
Genetic correlation with associated traits
We used LD score regression, which has been described in detail
elsewhere (49), to calculate the genetic correlation between
2D:4D ratio and a range of traits and diseases it has been associ-
ated with in observational studies. Note that, we conducted this
analysis using the European only meta-analysis results as LD
score regression cannot accommodate LD variation between di-
verse populations. Briefly, the LD score is a measure of how
much genetic variation each SNP tags; so if a SNP has a high LD
score then it is in high LD with many nearby SNPs. SNPs with
high LD scores are more likely to contain more true signals and
hence provide more chance for overlap with genuine signals be-
tween GWAS. The method uses summary statistics from the
GWAS meta-analyses of 2D:4D ratio and the traits of interest,
calculates the cross-product of test statistics at each SNP, and
then regresses the cross-product on the LD score. The slope of
the regression is a function of the genetic correlation between
traits. If there is overlap between the samples used in each of
the meta-analyses (or cryptic relatedness between samples) it
will only affect the intercept of the regression, and will not bias
the estimate of the genetic covariance.
Summary statistics from the GWAS meta-analysis for traits
and diseases of interest were downloaded from the relevant
consortium website (see Supplementary Material, Table S8 for
references). The summary statistics files were reformatted for
LD score regression analysis using the munge_sumstats.py py-
thon script provided on the developer’s website (https://github.
com/bulik/ldsc; date last accessed August 10, 2017); we filtered
the summary statistics to the subset of HapMap3 SNPs, as ad-
vised by the developers, to ensure that no bias was introduced
due to poor imputation quality. Where the sample size for each
SNP was included in the results file was flagged using –N-col; if
no sample size was available then the maximum sample size
reported in the reference for the GWAS meta-analysis was used
(i.e. the summary statistics for each SNP was assumed to have
been estimated using the same sample size). SNPs were ex-
cluded if the minor allele frequency was<0.01, the strand was
ambiguous, the rs number was duplicated or they had a sample
size less than 60% of the total sample size available. Once all the
files were reformatted, we used the ldsc.py python script, also
on the developer’s website, to calculate the genetic correlation
between 2D:4D ratio and each of the traits and diseases. The
European LD Score files that were calculated from the 1000
Genomes reference panel and provided by the developers were
used for the analysis.
Supplementary Material
Supplementary Material is available at HMG online.
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